Impact of ketamine as an adjunct sedative in acute respiratory distress syndrome due to COVID-19 Pneumonia. Garner O, Patterson J, Mejia JM, Anand V, et al. Respir Med 2021;189:106667.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Garner O, Patterson J, Mejia JM, Anand V, et al. Impact of ketamine as an adjunct sedative in acute respiratory distress syndrome due to COVID-19 Pneumonia. Respir Med 2021;189:106667.
PMID: 34757277